Co-Authors
This is a "connection" page, showing publications co-authored by Bruno Moulin and Samira Fafi-Kremer.
Connection Strength
1.202
-
In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant. 2020 11; 20(11):3162-3172.
Score: 0.226
-
Torquetenovirus viremia for early prediction of graft rejection after kidney transplantation. J Infect. 2019 07; 79(1):56-60.
Score: 0.206
-
The Authors Reply. J Am Soc Nephrol. 2018 05; 29(5):1578.
Score: 0.189
-
Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy. J Am Soc Nephrol. 2018 01; 29(1):326-334.
Score: 0.184
-
Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19. Am J Transplant. 2021 11; 21(11):3808-3810.
Score: 0.060
-
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int. 2021 06; 99(6):1498-1500.
Score: 0.059
-
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients. Kidney Int. 2021 06; 99(6):1487-1489.
Score: 0.059
-
Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients. Transplantation. 2021 01 01; 105(1):158-169.
Score: 0.058
-
Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Eur J Neurol. 2021 01; 28(1):248-258.
Score: 0.057
-
First case of COVID-19 in a kidney transplant recipient treated with belatacept. Am J Transplant. 2020 Jul; 20(7):1944-1946.
Score: 0.055
-
Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: A multicenter retrospective study. Transpl Infect Dis. 2019 Apr; 21(2):e13058.
Score: 0.051